This website is intended for healthcare professionals only

Trending Topic

6 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

The Pediatric Dermatology Research Alliance (PeDRA) is helping to build a stronger, more sustainable research workforce by providing funding, mentorship, training and collaborative opportunities for investigators at every career stage. Dr Colleen Cotton discusses the challenges facing pediatric dermatology research and why investing in the next generation is essential to improving care for children with skin diseases.

Advancing vitiligo care: Prof. Viktoria Eleftheriadou joins the touchDERMATOLOGY Editorial Board

3 mins
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Aug 13th 2026

Prof. Eleftheriadou reflects on what drew her to dermatology, the advances transforming patient care, and her hopes for more effective vitiligo treatment. 


hassan galadari

“An effective treatment that could reliably halt disease progression and restore pigmentation would not only improve physical outcomes but also have a meaningful emotional and psychological benefit for hundreds of thousands of patients.”

We are delighted to welcome Prof. Viktoria Eleftheriadou to the Editorial Board of our flagship journal, touchREVIEWS in Dermatology.

Prof. Eleftheriadou is a Consultant Dermatologist and the Lead for the Vitiligo Clinic and Research service for adult and pediatric patients at Walsall Healthcare and The Royal Wolverhampton NHS Trusts, UK.

She frequently presents at national and international conferences and currently leads several national and international projects, including the Global Vitiligo Atlas (GLOVA), a project of the International League of Dermatological Societies (ILDS), for which she serves as co-director.

Prof. Eleftheriadou is also a Clinical Professor at the Institute for Global Health and Wellbeing, School of Medicine, Keele University, and has received multiple awards from the European Academy of Dermatology and Venereology (EADV), the British Association of Dermatologists (BAD) and the American Academy of Dermatology (AAD).

New insights are added regularly, covering a broad range of subspecialties. Sign up below for free access to the latest clinical updates in your specialty!


To officially welcome Prof. Eleftheriadou to the Editorial Board and get to know her a little better, we invited her to reflect on what drew her to dermatology, the achievements that have surprised her most, and the innovation she would most like to see in everyday practice.


What drew you to your chosen specialty?

Since medical school, I was drawn to dermatology because of its unique combination of clinical variety, continuity of care, and visual impact. I enjoy managing a broad spectrum of conditions, from skin cancer to complex inflammatory diseases, while caring for patients across all stages of life, from infants to the elderly.

What I find most rewarding is seeing the visible improvement in a patient’s skin and confidence, often within a relatively short period of time, and knowing the meaningful difference this can make to their everyday life.


What experiences in your career to date have surprised you most?

One of the most surprising aspects of my career has been how quickly dermatology continues to evolve, particularly with advances in biologic therapies and dermatological surgery. It has been rewarding to be part of a specialty where innovation can so rapidly transform patient care.

I have also valued the opportunities to influence research and clinical trials on a global level, mentor junior colleagues, and work within multidisciplinary teams, all of which have been highlights of my career so far.


If you could bring one innovation instantly into everyday practice, what would it be?

If I could bring one innovation instantly into everyday practice, it would be a universally effective and accessible treatment for vitiligo. Although significant advances have been made in recent years, we still have a long way to go.

An effective treatment that could reliably halt disease progression and restore pigmentation would not only improve physical outcomes but also have a meaningful emotional and psychological benefit for hundreds of thousands of patients.


What is one small thing that always brightens a busy working day for you?

Genuine moments of appreciation can be incredibly rewarding and serve as a reminder of the meaningful impact dermatology can have on patients’ lives.


Cite: Advancing vitiligo are: Prof. Viktoria Eleftheriadou joins the touchDERMATOLOGY Editorial Board. touchDERMATOLOGY. August 12, 2026.

Disclosures: This content has been developed independently by Touch Medical Media for touchDERMATOLOGY in collaboration with Prof. Eleftheriadou. Views expressed are the speaker’s own and do not necessarily reflect the views of Touch Medical Media.


SIGN UP to TouchDERMATOLOGY!

Join our global community today for access to thousands of peer-reviewed articles, expert insights, and learn-on-the-go education across 150+ specialties, plus concise email updates and newsletters so you never miss out.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup